Business Information
The group's principal activities are to develop, manufacture and sell ethical drug products, which require physician's prescription, as well as non-prescription pharmaceutical products sold over-the-counter. The products consist of ethical drug specialties marketed to physicians by the group's forest pharmaceuticals, forest therapeutics, forest healthcare and forest specialty sales salesforces. The products of the group include namendatm, for moderate to severe alzheimer's disease, lexapro(R), for generalized anxiety disorder, celexa, for depression, benicar(R) and lercanidipine, for hypertension, acamprosate, for alcohol dependence and tiazac(R), for hypertension and angina. The major customers of the group are mckesson drug corporation, cardinal health, inc. And amerisourcebergen corporation. The group operates in the United States, the United Kingdom and Ireland.
|
|
Name |
Title
|
Email
|
| Howard Solomon | Chmn., CEO | N/A | | Francis Perier | CFO, Sr. VP - Finance | N/A | | Lawrence Olanoff | COO, Pres. | N/A | | Elaine Hochberg | Sr. VP - Marketing | N/A | | Ivan Gergel | Sr. VP - Scientific Affairs | N/A |
|
|
Year |
Sales |
Net Income |
| 2007 | 3,441,785 | 454,103 | | 2006 | 2,962,390 | 708,514 | | 2005 | 3,159,639 | 838,805
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
